Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AKRO – Akero Therapeutics Inc

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=AKRO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=AKRO &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

11.49

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

-0.12

EPS Last/This Y

0.03

EPS This/Next Y

-0.61

Price

49.18

Target Price

75.27

Analyst Recom

1

Performance Q

0.53

Relative Volume

0.57

Beta

-0.23

Ticker: AKRO




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25AKRO50.530.350.2934097
2025-07-28AKRO49.360.350.1734342
2025-07-29AKRO47.510.350.0134482
2025-07-30AKRO47.710.340.0535063
2025-07-31AKRO48.860.340.0535532
2025-08-01AKRO48.170.330.0335802
2025-08-04AKRO48.620.330.1335846
2025-08-05AKRO49.560.330.4635793
2025-08-06AKRO52.990.330.0035840
2025-08-07AKRO50.370.290.0339787
2025-08-08AKRO50.460.290.3340867
2025-08-11AKRO48.310.290.1440850
2025-08-12AKRO48.030.320.0439502
2025-08-13AKRO48.320.322.2239534
2025-08-14AKRO50.110.341.4840161
2025-08-15AKRO49.390.360.7440640
2025-08-18AKRO48.60.220.0322475
2025-08-19AKRO47.60.200.0725099
2025-08-20AKRO47.940.190.0426344
2025-08-21AKRO48.260.190.1026587
2025-08-22AKRO49.220.190.0426613
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25AKRO50.56-6.2-80.1-3.78
2025-07-28AKRO49.47-6.2-70.8-3.78
2025-07-29AKRO47.49-6.2-65.1-3.78
2025-07-30AKRO47.72-6.2-81.5-3.78
2025-07-31AKRO48.85-6.2-89.6-3.78
2025-08-01AKRO48.37-7.6-75.7-3.78
2025-08-04AKRO48.62-7.6-81.8-3.78
2025-08-05AKRO49.56-7.6-87.7-3.78
2025-08-06AKRO52.80-7.6-106.6-3.78
2025-08-07AKRO50.45-11.1-61.7-3.84
2025-08-08AKRO50.46-11.1-79.7-3.84
2025-08-11AKRO48.33-11.1-62.4-3.84
2025-08-12AKRO48.0714.2-63.2-3.72
2025-08-13AKRO48.3114.2-56.0-3.72
2025-08-14AKRO50.1612.5-80.0-3.72
2025-08-15AKRO49.3812.5-58.0-3.72
2025-08-18AKRO48.5812.5-57.1-3.72
2025-08-19AKRO47.6012.5-55.3-3.72
2025-08-20AKRO47.9512.5-67.0-3.72
2025-08-21AKRO48.2612.5-66.6-3.72
2025-08-22AKRO49.1812.5-71.6-3.72
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25AKRO-2.8522.2011.37
2025-07-28AKRO-2.8521.8411.37
2025-07-29AKRO-2.8521.8411.37
2025-07-30AKRO-2.0621.8411.37
2025-07-31AKRO-2.0621.8411.37
2025-08-01AKRO-0.8021.8411.37
2025-08-04AKRO-0.8020.8011.37
2025-08-05AKRO-0.8020.8011.37
2025-08-06AKRO-0.6720.8011.37
2025-08-07AKRO-0.8320.8011.37
2025-08-08AKRO-3.0320.8011.37
2025-08-11AKRO-3.0320.7611.37
2025-08-12AKRO-2.6720.7611.31
2025-08-13AKRO-2.7020.7611.27
2025-08-14AKRO-3.2020.7611.27
2025-08-15AKRO-3.2520.7611.26
2025-08-18AKRO-3.2516.5411.49
2025-08-19AKRO-2.7516.5411.49
2025-08-20AKRO-2.7516.5411.49
2025-08-21AKRO-2.7516.5411.49
2025-08-22AKRO-2.6416.5411.49
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=AKRO 589 360 ]

Last Quarter Act. EPS

-0.86

Avg. EPS Est. Current Quarter

-0.92

Avg. EPS Est. Next Quarter

-0.98

Insider Transactions

-2.64

Institutional Transactions

16.54

Beta

-0.23

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

17

Growth Score

18

Sentiment Score

8

Actual DrawDown %

15.8

Max Drawdown 5-Year %

-80

Target Price

75.27

P/E

Forward P/E

PEG

P/S

P/B

3.84

P/Free Cash Flow

EPS

-3.8

Average EPS Est. Cur. Y​

-3.72

EPS Next Y. (Est.)

-4.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.57

Return on Equity vs Sector %

-52.4

Return on Equity vs Industry %

-39.5

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.05

EBIT Estimation

-71.6
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=AKRO 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=AKRO 589 450 ]
Akero Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 67
Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
stock quote shares AKRO – Akero Therapeutics Inc Stock Price stock today
news today AKRO – Akero Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch AKRO – Akero Therapeutics Inc yahoo finance google finance
stock history AKRO – Akero Therapeutics Inc invest stock market
stock prices AKRO premarket after hours
ticker AKRO fair value insiders trading